180 related articles for article (PubMed ID: 19464392)
1. Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis.
Bargagli E; Olivieri C; Nikiforakis N; Cintorino M; Magi B; Perari MG; Vagaggini C; Spina D; Prasse A; Rottoli P
Respir Physiol Neurobiol; 2009 Jul; 167(3):261-7. PubMed ID: 19464392
[TBL] [Abstract][Full Text] [Related]
2. Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis.
Rottoli P; Magi B; Cianti R; Bargagli E; Vagaggini C; Nikiforakis N; Pallini V; Bini L
Proteomics; 2005 Jul; 5(10):2612-8. PubMed ID: 15924291
[TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor in lung tissue of idiopathic pulmonary fibrosis patients.
Olivieri C; Bargagli E; Inghilleri S; Campo I; Cintorino M; Rottoli P
Exp Lung Res; 2016 Jun; 42(5):263-6. PubMed ID: 27337548
[TBL] [Abstract][Full Text] [Related]
4. Protein profile in bronchoalveolar lavage fluid from patients with sarcoidosis and idiopathic pulmonary fibrosis as revealed by SDS-PAGE electrophoresis and western blot analysis.
Uebelhoer M; Bewig B; Oldigs M; Nowak D; Magnussen H; Petermann W; Barth J
Scand J Clin Lab Invest; 1993 Oct; 53(6):617-23. PubMed ID: 8266009
[TBL] [Abstract][Full Text] [Related]
5. Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases.
Reichenberger F; Schauer J; Kellner K; Sack U; Stiehl P; Winkler J
Lung; 2001; 179(3):163-74. PubMed ID: 11891606
[TBL] [Abstract][Full Text] [Related]
6. Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
Nakayama S; Mukae H; Ishii H; Kakugawa T; Sugiyama K; Sakamoto N; Fujii T; Kadota J; Kohno S
Respir Med; 2005 Sep; 99(9):1145-51. PubMed ID: 16085216
[TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin-2 receptor in blood from patients with sarcoidosis and idiopathic pulmonary fibrosis.
Tsutsumi T; Nagai S; Imai K; Setoyama Y; Uchiyama T; Izumi T
Sarcoidosis; 1994 Sep; 11(2):102-9. PubMed ID: 7809492
[TBL] [Abstract][Full Text] [Related]
8. Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study.
Magi B; Bini L; Perari MG; Fossi A; Sanchez JC; Hochstrasser D; Paesano S; Raggiaschi R; Santucci A; Pallini V; Rottoli P
Electrophoresis; 2002 Sep; 23(19):3434-44. PubMed ID: 12373774
[TBL] [Abstract][Full Text] [Related]
9. Morphological and biochemical properties of alveolar fibroblasts in interstitial lung diseases.
Fireman E; Shahar I; Shoval S; Messer G; Dvash S; Grief J
Lung; 2001; 179(2):105-17. PubMed ID: 11733853
[TBL] [Abstract][Full Text] [Related]
10. [The pathogenic role of macrophage migration inhibitory factor in acute respiratory distress syndrome].
Guo Y; Xie C
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):337-40. PubMed ID: 12126556
[TBL] [Abstract][Full Text] [Related]
11. Elevated macrophage migration inhibitory factor (MIF) levels in the urine of patients with focal glomerular sclerosis.
Matsumoto K; Maruyama N; Maruyama T; Ohnishi Y; Nonaka S; Inoshita A; Ito K; Kitajima S; Abe M; Satomura A; Fujita T
Clin Exp Immunol; 2005 Feb; 139(2):338-47. PubMed ID: 15654833
[TBL] [Abstract][Full Text] [Related]
12. Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseases.
Kibiki GS; van der Ven AJ; Geurts-Moespot A; Shao J; Calandra T; Sweep FC; Dolmans WM
Clin Immunol; 2007 Apr; 123(1):60-5. PubMed ID: 17275414
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of interleukin-13 in the serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis].
Xiao L; Li ZH; Hou XM; Yu RJ
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Nov; 26(11):686-8. PubMed ID: 14703444
[TBL] [Abstract][Full Text] [Related]
14. Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome.
Willeke P; Gaubitz M; Schotte H; Maaser C; Domschke W; Schlüter B; Becker H
Arthritis Res Ther; 2007; 9(2):R43. PubMed ID: 17470266
[TBL] [Abstract][Full Text] [Related]
15. [Effects of macrophage migration inhibitory factor in pathogenesis of acute respiratory distress syndrome in children].
Tang YB; Qiu SY; Jiang F; Yi L; Guo L
Zhonghua Er Ke Za Zhi; 2006 May; 44(5):356-9. PubMed ID: 16780713
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between macrophage migration inhibitory factor and cardiac function in patients with congestive heart failure].
Liu Y; Yu XY; Lin QX; Yang M; Shan ZX; Zheng M
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1169-70. PubMed ID: 14625178
[TBL] [Abstract][Full Text] [Related]
17. Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis.
Brown FG; Nikolic-Paterson DJ; Hill PA; Isbel NM; Dowling J; Metz CM; Atkins RC
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S7-13. PubMed ID: 11792756
[TBL] [Abstract][Full Text] [Related]
18. Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki disease.
Lee TJ; Chun JK; Yeon SI; Shin JS; Kim DS
Scand J Rheumatol; 2007; 36(3):222-5. PubMed ID: 17657678
[TBL] [Abstract][Full Text] [Related]
19. [Change of prostaglandin E2 and interleukin-12, interleukin-13 in the bronchoalveolar lavage fluid and the serum of the patients with idiopathic pulmonary fibrosis].
Li JZ; Li ZH; Kang J; Hou XM; Yu RJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jun; 27(6):378-80. PubMed ID: 15256084
[TBL] [Abstract][Full Text] [Related]
20. Surfactant protein-A in lung lavage fluid obtained from patients with idiopathic pulmonary fibrosis.
Behera D; Kaur S; Sathyanarayana G; Majumdar S
J Assoc Physicians India; 2002 Nov; 50():1409-12. PubMed ID: 12583473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
